Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class…
:max_bytes(150000):strip_icc()/3231789_color1-5c0175fc46e0fb00014ab433.png "Viridian Therapeutics Announces Positive Topline Results from Veligrotug (VRDN-001) Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease")
PHARMA & CLINICAL TRIALS
China delivered its first domestically developed mpox vaccine into clinical trials on Monday. The vaccine,…
New research involving UC College of Medicine may lead to finding effective therapies faster Researchers…
A deeper understanding of the communication inside the body when someone is going through opioid…
The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, and world-renowned…
The Biden administration announced on Aug. 16, 2024, the reduced prices of the first 10…
Drugmakers will receive flat fees for new medicines in push to avoid encouraging overuse Please…
The World Mitochondria Society (WMS) and the International Society of Microbiota (ISM) are proud to…
Eli Lilly,said in a social media post, opens new tab Friday its weight loss drug tirzepatide…
Cyclodextrins (CDs) are complicated carbohydrates, a term that describes the natural, sugar-based, starchy material that…
